Zacks Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $241K | Hold |
865
| – | – | ﹤0.01% | 627 |
|
|
2025
Q4 | $262K | Hold |
865
| – | – | ﹤0.01% | 614 |
|
|
2025
Q3 | $243K | Sell |
865
-14
| -2% | -$3.81K | ﹤0.01% | 631 |
|
|
2025
Q2 | $212K | Buy |
+879
| New | +$208K | ﹤0.01% | 629 |
|
|
2025
Q1 | – | Sell |
-632
| Closed | -$208K | – | 664 |
|
|
2024
Q4 | $208K | Sell |
632
-988
| -61% | -$335K | ﹤0.01% | 623 |
|
|
2024
Q3 | $542K | Buy |
+1,620
| New | +$515K | ﹤0.01% | 481 |
|
|
2024
Q2 | – | Sell |
-887
| Closed | -$307K | – | 639 |
|
|
2024
Q1 | $307K | Buy |
887
+15
| +2% | +$4.93K | ﹤0.01% | 533 |
|
|
2023
Q4 | $282K | Sell |
872
-26
| -3% | -$8.15K | ﹤0.01% | 538 |
|
|
2023
Q3 | $322K | Sell |
898
-47
| -5% | -$18.1K | ﹤0.01% | 500 |
|
|
2023
Q2 | $358K | Sell |
945
-11,019
| -92% | -$4.48M | ﹤0.01% | 502 |
|
|
2023
Q1 | $5.73M | Buy |
11,964
+5,722
| +92% | +$2.68M | 0.08% | 178 |
|
|
2022
Q4 | $2.62M | Sell |
6,242
-227
| -4% | -$91.6K | 0.04% | 251 |
|
|
2022
Q3 | $2.7M | Buy |
6,469
+5,682
| +722% | +$2.83M | 0.04% | 230 |
|
|
2022
Q2 | $389K | Sell |
787
-3,825
| -83% | -$1.99M | 0.01% | 458 |
|
|
2022
Q1 | $2.6M | Buy |
4,612
+3,871
| +522% | +$2.33M | 0.04% | 253 |
|
|
2021
Q4 | $560K | Buy |
741
+1
| +0.1% | +$748 | 0.01% | 441 |
|
|
2021
Q3 | $552K | Sell |
740
-1
| -0.1% | -$749 | 0.01% | 440 |
|
|
2021
Q2 | $477K | Hold |
741
| – | – | 0.01% | 458 |
|
|
2021
Q1 | $423K | Hold |
741
| – | – | 0.01% | 430 |
|
|
2020
Q4 | $432K | Hold |
741
| – | – | 0.01% | 434 |
|
|
2020
Q3 | $382K | Hold |
741
| – | – | 0.01% | 428 |
|
|
2020
Q2 | $335K | Sell |
741
-32
| -4% | -$14.1K | 0.01% | 430 |
|
|
2020
Q1 | $271K | Buy |
773
+24
| +3% | +$8.82K | 0.01% | 443 |
|
|
2019
Q4 | $277K | Buy |
749
+1
| +0.1% | +$353 | 0.01% | 494 |
|
|
2019
Q3 | $249K | Sell |
748
-3,489
| -82% | -$1.14M | 0.01% | 490 |
|
|
2019
Q2 | $1.32M | Buy |
4,237
+3,493
| +469% | +$1.05M | 0.03% | 354 |
|
|
2019
Q1 | $228K | Buy |
+744
| New | +$201K | ﹤0.01% | 502 |
|
|
2018
Q4 | – | Sell |
-744
| Closed | -$233K | – | 514 |
|
|
2018
Q3 | $233K | Sell |
744
-454
| -38% | -$141K | ﹤0.01% | 484 |
|
|
2018
Q2 | $346K | Buy |
+1,198
| New | +$331K | 0.01% | 479 |
|
|
2016
Q1 | – | Sell |
-9,759
| Closed | -$1.35M | – | 607 |
|
|
2015
Q4 | $1.35M | Sell |
9,759
-2,492
| -20% | -$345K | 0.04% | 246 |
|
|
2015
Q3 | $1.65M | Buy |
12,251
+305
| +3% | +$43.9K | 0.06% | 212 |
|
|
2015
Q2 | $1.8M | Buy |
+11,946
| New | +$1.71M | 0.06% | 196 |
|
|
2014
Q4 | – | Sell |
-2,331
| Closed | -$264K | – | 632 |
|
|
2014
Q3 | $264K | Sell |
2,331
-373
| -14% | -$44.2K | 0.01% | 567 |
|
|
2014
Q2 | $324K | Sell |
2,704
-18
| -0.7% | -$2.2K | 0.01% | 552 |
|
|
2014
Q1 | $349K | Sell |
2,722
-2,311
| -46% | -$296K | 0.01% | 513 |
|
|
2013
Q4 | $622K | Buy |
5,033
+1,679
| +50% | +$205K | 0.02% | 329 |
|
|
2013
Q3 | $394K | Sell |
3,354
-1,329
| -28% | -$157K | 0.02% | 426 |
|
|
2013
Q2 | $525K | Buy |
+4,683
| New | +$549K | 0.02% | 300 |
|
Other funds holding BIO
VCM
VPM
AI
